By establishing an RI/RI model in streptozotocin (STZ)-induced diabetic rats, we attempted to test the following hypothesis: IsoP reduces oxidative stress, inflammation, and apoptosis via activation of the Brg1/Nrf2 signaling pathway in the context of diabetes, thereby mitigating RI/RI. Here, SMARCA4 is linked to diabetes mellitus.